Patents Assigned to 3R Life Sciences Ltd.
  • Patent number: 11285254
    Abstract: The present invention provides a method, system, and apparatus that can substantially reduce the recirculation of venovenous extracorporeal membrane oxygenation (VV ECMO) associated with the two-site, single-lumen cannulation approach. Actively-controlled flow regulators comprising balloon, occluder and reservoir can be individually or collectively equipped on the drainage and/or infusion cannulas to accomplish the goal of maximizing VV ECMO support efficacy. Three specific embodiments are introduced to illustrate the practical enforcement of the proposed blood flow control in reference to the heart rhythm, aiming at achieving the maximal reduction of oxygenated blood flow recirculating back to the VV ECMO circuit.
    Type: Grant
    Filed: July 12, 2017
    Date of Patent: March 29, 2022
    Assignee: 3R Life Sciences Ltd.
    Inventors: Pong-Jeu Lu, Hsiao-Chien Lin